A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes

NCT01513590 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

394

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin degludec/insulin aspart

Sponsor

Novo Nordisk A/S